EXPERTISE
Life Sciences & Healthcare

Czech Republic: COVID-19 Legal Analysis: Employment – Data Protection – Contracts – Damages

26 March 2020 – The COVID-19 virus continues to spread around the globe, and the rate of infection in the Czech Republic is also increasing dramatically. Understandably, the main goal for everyone at present is to remain safe and healthy. But at the...

Slovakia: Overview of current extraordinary measures related to COVID-19

18 March 2020 – It may be challenging for non-Slovak speakers to understand what the “state of emergency” declared by the Slovak government means, in particular if you are still required to manage your business and/or employees in Slovakia, while...

Slovakia: COVID-19 - Key recommendations for employers

13 March 2020 – This article has been prepared by Kinstellar’s team in Bratislava based on frequently asked client questions and contains key legal recommendations for employers in Slovakia regarding the spread of the COVID-19 coronavirus.

Kinstellar completes the acquisition of Walmark

March 2020 – Kinstellar has advised STADA Arzneimittel on the completion of the previously announced acquisition of Walmark, a leading consumer healthcare company in Central Europe, with a direct presence across nine EU countries and sales in more than...

Peter Kováč leads expert medical congress in Bratislava co-sponsored by Kinstellar

November 2019 – Peter Kováč, Of Counsel and leader of the Life Sciences & Healthcare practice in Kinstellar’s Bratislava office, served as lead organiser for the expert medical congress “Legal, Forensic and Economic Aspects of the Medical...

New obligations under the Slovak Cyber Security Act

November 2019 – The Slovak Cyber Security Act (Act No. 69/2018 Coll., the “Act”) defines the minimum requirements to ensure cyber security in Slovakia. The Act applies to operators of essential services, i.e., to entities in key sectors, including...

Kinstellar advises Bain & Cinven-backed STADA Arzneimittel on acquisition of Walmark

November 2019 – Kinstellar advised STADA Arzneimittel on the acquisition of Walmark, a leading manufacturer of consumer health products in Central Europe from Mid Europa Partners for an undisclosed amount. The transaction is subject to merger control...

Kinstellar co-authors the first-ever Bulgarian country report of the Pharma Legal Handbook series

September 2019 – The first-ever Bulgarian country report of the Pharma Legal Handbook series is now available thanks to the joint efforts of Svilen Issaev, Counsel at Kinstellar’s Sofia office, and Petko Konakchiev, co-founder of PharmaDedict, a private...

Cannabis for Medical Use: CEE Regulatory Update

June 2019 – A growing number of countries around the world are gradually legalising the use of cannabis for medical purposes.

Slovak Data Protection Authority fines Faculty Hospital Nitra for providing medical records to expert witness

May 2019 – The Slovak Data Protection Authority (“Slovak DPA”) has fined Faculty Hospital Nitra EUR 2,000 for unlawfully processing sensitive personal data in breach of § 13 section 1 of Act. No 122/2013 Coll., On Personal Data Protection (“Data...